Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis

BackgroundThere has existed controversy regarding the use of Ginkgo biloba (GKB) for blood metabolism among type 2 diabetes mellitus(T2DM) patients, and we tried to analyze the effects and safety of GKB on T2DM patients.MethodsWe conducted a literature search between January 2003 and December 2022 o...

Full description

Bibliographic Details
Main Authors: Huimin Zou, Jingxian Fang, Yu Han, Xue Hu, Jian Meng, Fang Huang, Hui Xu, Chengfei Lu, Yiwen Wang, Lili Zhang, Xiaohong Dong, Yanmei Yu, Yu Guo, Qing Gu, Suijun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1231053/full
_version_ 1797360643757572096
author Huimin Zou
Jingxian Fang
Yu Han
Xue Hu
Jian Meng
Fang Huang
Hui Xu
Chengfei Lu
Yiwen Wang
Lili Zhang
Xiaohong Dong
Yanmei Yu
Yu Guo
Qing Gu
Suijun Wang
author_facet Huimin Zou
Jingxian Fang
Yu Han
Xue Hu
Jian Meng
Fang Huang
Hui Xu
Chengfei Lu
Yiwen Wang
Lili Zhang
Xiaohong Dong
Yanmei Yu
Yu Guo
Qing Gu
Suijun Wang
author_sort Huimin Zou
collection DOAJ
description BackgroundThere has existed controversy regarding the use of Ginkgo biloba (GKB) for blood metabolism among type 2 diabetes mellitus(T2DM) patients, and we tried to analyze the effects and safety of GKB on T2DM patients.MethodsWe conducted a literature search between January 2003 and December 2022 of seven online databases (PubMed, Scopus, Embase, Google Scholar, Web of Sciences, Cochrane Library, and China National Knowledge Infrastructure). A systematic literature review and meta-analysis were performed to compare the effects and safety of GKB among T2DM patients. Four groups of parameters were extracted and analyzed: hemorheology parameters, lipid profile, glycemic control markers, and adverse events.ResultsIn the end, 13 eligible articles with 11 indicators among 1573 patients were included. In the hemorheology parameters section, GKB showed significantly lower plasma viscosity (PV) (SMD=-0.91, 95%CI [-1.45, -0.36], P<0.01) and hematocrit (Hct) (SMD=-0.60, 95%CI [-0.97, -0.24], P<0.01) than the control group. GKB shoed higher velocity of the dorsalis pedis artery (VDPA) (SMD=0.51, 95%CI [0.26, 0.76], P<0.01) and ankle brachial index (ABI) (SMD=0.71, 95%CI [0.32, 1.10], P<0.01) than the control. In both the lipid profile and glycemic control markers sections, we did not find any difference between GKB and control groups, including total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting serum glucose (FSG). In addition, we saw no difference in adverse events (AE). The sensitivity analysis and funnel plot showed that the results in this research were robust and had no publication bias.ConclusionIn conclusion, GKB might safely reduce the risk of peripheral arterial or even systemic cardiovascular disease. However, GKB did not directly improve lipid and blood glucose levels in T2DM patients.Systematic review registrationhttps://inplasy.com/, identifier INPLASY202350096.
first_indexed 2024-03-08T15:42:37Z
format Article
id doaj.art-3689fdcc8cc04d7a9bd2962ac36a69b1
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-08T15:42:37Z
publishDate 2024-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-3689fdcc8cc04d7a9bd2962ac36a69b12024-01-09T14:32:23ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922024-01-011410.3389/fendo.2023.12310531231053Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysisHuimin ZouJingxian FangYu HanXue HuJian MengFang HuangHui XuChengfei LuYiwen WangLili ZhangXiaohong DongYanmei YuYu GuoQing GuSuijun WangBackgroundThere has existed controversy regarding the use of Ginkgo biloba (GKB) for blood metabolism among type 2 diabetes mellitus(T2DM) patients, and we tried to analyze the effects and safety of GKB on T2DM patients.MethodsWe conducted a literature search between January 2003 and December 2022 of seven online databases (PubMed, Scopus, Embase, Google Scholar, Web of Sciences, Cochrane Library, and China National Knowledge Infrastructure). A systematic literature review and meta-analysis were performed to compare the effects and safety of GKB among T2DM patients. Four groups of parameters were extracted and analyzed: hemorheology parameters, lipid profile, glycemic control markers, and adverse events.ResultsIn the end, 13 eligible articles with 11 indicators among 1573 patients were included. In the hemorheology parameters section, GKB showed significantly lower plasma viscosity (PV) (SMD=-0.91, 95%CI [-1.45, -0.36], P<0.01) and hematocrit (Hct) (SMD=-0.60, 95%CI [-0.97, -0.24], P<0.01) than the control group. GKB shoed higher velocity of the dorsalis pedis artery (VDPA) (SMD=0.51, 95%CI [0.26, 0.76], P<0.01) and ankle brachial index (ABI) (SMD=0.71, 95%CI [0.32, 1.10], P<0.01) than the control. In both the lipid profile and glycemic control markers sections, we did not find any difference between GKB and control groups, including total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting serum glucose (FSG). In addition, we saw no difference in adverse events (AE). The sensitivity analysis and funnel plot showed that the results in this research were robust and had no publication bias.ConclusionIn conclusion, GKB might safely reduce the risk of peripheral arterial or even systemic cardiovascular disease. However, GKB did not directly improve lipid and blood glucose levels in T2DM patients.Systematic review registrationhttps://inplasy.com/, identifier INPLASY202350096.https://www.frontiersin.org/articles/10.3389/fendo.2023.1231053/fullGinkgo bilobaGKBtype 2 diabetes mellitusT2DMmeta-analysis
spellingShingle Huimin Zou
Jingxian Fang
Yu Han
Xue Hu
Jian Meng
Fang Huang
Hui Xu
Chengfei Lu
Yiwen Wang
Lili Zhang
Xiaohong Dong
Yanmei Yu
Yu Guo
Qing Gu
Suijun Wang
Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
Frontiers in Endocrinology
Ginkgo biloba
GKB
type 2 diabetes mellitus
T2DM
meta-analysis
title Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
title_full Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
title_fullStr Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
title_full_unstemmed Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
title_short Effects and safety of Ginkgo biloba on blood metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis
title_sort effects and safety of ginkgo biloba on blood metabolism in type 2 diabetes mellitus a systematic review and meta analysis
topic Ginkgo biloba
GKB
type 2 diabetes mellitus
T2DM
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1231053/full
work_keys_str_mv AT huiminzou effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT jingxianfang effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT yuhan effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT xuehu effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT jianmeng effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT fanghuang effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT huixu effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT chengfeilu effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT yiwenwang effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT lilizhang effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT xiaohongdong effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT yanmeiyu effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT yuguo effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT qinggu effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis
AT suijunwang effectsandsafetyofginkgobilobaonbloodmetabolismintype2diabetesmellitusasystematicreviewandmetaanalysis